Page 16 - Astrazeneca

Vaccine leadership, not chauvinism

The WHO's initiative to provide equitable access to vaccines - COVAX - is devoid of the funds needed to procure and supply the shots to poorer countries.

AstraZeneca's Dapagliflozin tablets get DCGI nod for chronic kidney disease

AstraZeneca Pharma India on Saturday said it has received approval from the Drugs Controller General of India (DCGI) for Dapagliflozin

Oxford says Covid-19 vaccine with AstraZeneca works against UK variant

The variant, first identified in Kent, southern England, is more easily transmissible, prompting many countries to restrict travel to Britain

Extra Astra vaccine data highlights efficacy in elderly: UK regulators

Britain has been rolling out the shot among all age groups after the Medicines and Healthcare products Regulatory Agency (MHRA) was the first regulator to approve it in December

AstraZeneca and Pfizer Covid-19 vaccines to be combined in Oxford trial

The Astra and Pfizer vaccines will be given in different orders and with two dosing intervals, four and 12 weeks apart.

Sputnik-AstraZeneca Covid-19 vaccine trials to start in Azerbaijan, MidEast

AstraZeneca said in December it would start clinical trials to test combining the two vaccines to see if this could boost the efficacy of the British shot.

Iran to start receiving Covid-19 vaccines developed by AstraZeneca in Feb

Namaki also said that Iran's Razi Vaccine and Serum Research Institute has been authorized to start clinical trials of its vaccine candidate, and they will hopefully start the trials next week

India to get around 97 million doses of AstraZeneca Covid-19 vaccine

As of now, Covax has not allotted the Pfizer-BioNTech vaccine for India.

India to get 97 million doses of Serum-made AstraZeneca vaccine from Covax

As of now, Covax has not disclosed the India distribution plan for the Pfizer-BioNTech vaccine

AstraZeneca vaccine drastically cut coronavirus transmission: Study

Researchers measured the impact on transmission by swabbing participants every week seeking to detect signs of the virus

France advises AstraZeneca Covid-19 vaccine only for people under 65 years

The decision could shake up the French vaccination strategy, because the country has prioritized nursing home residents and people over 75

Pfizer forecasts about $15 billion in 2021 sales from Covid-19 vaccine

Pfizer is commanding a higher price for its vaccine than some rivals

AstraZeneca to increase vaccine supply to EU: European Commission president

Pharmaceutical company AstraZeneca has promised to increase its vaccine supply to the European Union (EU), European Commission President Ursula von der Leyen said

European Union authorizes AstraZeneca/Oxford Covid-19 vaccine

The Covid-19 vaccine was developed by British firm AstraZeneca and Oxford University

EU authorises AstraZeneca Covid-19 vaccine, 400 mn doses to be available

It was the third Covid-19 vaccine authorised in the EU, after Pfizer/BioNTech and Moderna vaccines were given the greenlights in late December and early January

Covid-19 crisis: EU threatens to block exports of AstraZeneca vaccines

The European Commission is to lay out the criteria under which such exports would be evaluated on Friday

Japan to produce 90 mn AstraZeneca Covid doses amid supply constraints

Production will be undertaken by JCR Pharmaceuticals, a biotechnology company that does not have experience producing vaccines but can culture the necessary adenoviral vectors

Covid-19: European Union calls on AstraZeneca to honour commitments

AstraZeneca Chief Executive Pascal Soriot rejected claims that his company was failing to honour its commitments

Send all pre-paid doses of AstraZeneca despite plans to delay supply: EU

The commissioner stressed that the EU required AstraZeneca to provide a report regarding the company's activities, adding that the bloc would hold the second round of consultations with AstraZeneca

BS Reads: From deal-making to air lifting, how the world will be vaccinated

While mass airlifting of vaccines is yet to begin, global deal-making shows many interesting trends